852913-53-2

Basic information

• Product Name: (8a,9s)-10,11-dihydro-6'-Methoxy-cinchonan-9-aMine
• Synonyms: (8a,9s)-10,11-dihydro-6'-Methoxy-cinchonan-9-aMine;(8α,9S)-10,11-dihydro-6'-methoxy-Cinchonan-9-amine;(8α,9S)-9-amine-10,11-dihydro-6'-methoxy-Cinchonan;(8α,9S)-10,11-Dihydro-6'-methoxycinchonan-9-amine Trihydrochloride,99%e.e.;(8α, 9S)-10,11-Dihydro-6'-methoxycinchonan-9-amine trihydrochloride, min. 90%;9S)-10,11-Dihydro-6'-methoxycinchonan-9-amine trihydrochloride, min. 90%
• CAS NO: 852913-53-2
• Molecular Formula: C₂₀H₂₇N₃O
• Molecular Weight: 323.432
• Mol File: 852913-53-2.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 487.5±30.0 °C(Predicted)
• Appearance: white to off-white/Powder
• Density: 1.17±0.1 g/cm3(Predicted)
• PKA: 9.98±0.70(Predicted)
• Stability: store cold
• CAS DataBase Reference: (8a,9s)-10,11-dihydro-6'-Methoxy-cinchonan-9-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: (8a,9s)-10,11-dihydro-6'-Methoxy-cinchonan-9-aMine(852913-53-2)
• EPA Substance Registry System: (8a,9s)-10,11-dihydro-6'-Methoxy-cinchonan-9-aMine(852913-53-2)

Safety Data

• Hazardous Substances Data: 852913-53-2(Hazardous Substances Data)

Usage

Reactions

Chinchona alkaloid derivative that promotes high enantioselective.

Upstream product

• 522-66-7 dihydroquinine 
• 522-66-7 dihydroquinine 
• 168778-61-8 (8S,9S)-9-azido-(9-deoxy)epiquinine 
• 249731-47-3 9-mesylquinine 
• 130-95-0 Quinine 
• 1231763-32-8 (S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methanamine hydrochloride 
• 168778-61-8 (8S,9S)-9-azido-(9-deoxy)epiquinine 
• 249731-47-3 quinine 9O-methanesulfonate 
• 130-95-0 quinine 

Downstream Products

• 1204591-53-6 3-((3,5-bis(trifluoromethyl)benzyl)amino)-4-(((1S)-((2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)amino)cyclobut-3-ene-1,2-dione 
• 1630973-06-6 2-(diphenylphosphino)-N-((S)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)benzamide 
• 1312706-37-8 C₂₁H₂₅N₃OS 
• 1392097-67-4 C₂₉H₃₀F₆N₄O₂ 
• 1565829-19-7 3-((S)-((2S,4S,8R)-8-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methylamino)-4-(4-(trifluoromethyl)phenylamino)cyclobut-3-ene-1,2-dione 
• 1453102-93-6 N-((S)-((2S,4S,8R)-8-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)-4-methoxybenzenesulfonamide 
• 1398566-78-3 1-(2,6-diisopropylphenyl)-3-((1S)-((2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl)thiourea 
• 1352957-59-5 C₃₂H₃₀F₆N₄O₃ 
• 1204699-63-7 C₂₈H₂₉F₆N₃O₃S 
• 1021867-74-2 C₂₇H₃₈N₄OS 

Relevant articles and documents

Synthesis of novel crown ether-squaramides and their application as phase-transfer catalysts

This work presents the synthesis of six new phase-transfer organocatalysts in which the squaramide unit is directly linked to the nitrogen atom of an aza-crown ether. Four chiral skeletons, namely hydroquinine, quinine, cinchonine (cinchonas), and α-D-glu

D-Mannitol-derived novel chiral thioureas: Synthesis and application in asymmetric Henry reactions

Five novel thioureas have been obtained through multi-step reactions from D-Mannitol as starting material and applied as catalysts in the asymmetric Henry reaction. Using catalyst 7a, (1S,2R)-2-nitro-1-phenylpropan-1-ol containing two chiral centers was o

ASYMMETRIC SYNTHESIS OF FUNAPIDE

This invention is directed to asymmetric synthesis of funapide, which is useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.